Related Experiment Video
Updated: Oct 14, 2025

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
Published on: October 24, 2018
Pediatric ECMO: unfavorable outcomes are associated with inflammation and endothelial activation
Sherrill D Caprarola1, Derek K Ng2, Megan K Carroll2
1Department of Pediatrics, Division of Pediatric Cardiac Critical Care, Children's National Health System, Washington, DC, USA.
Insights
High levels of inflammatory and endothelial activation markers in children on extracorporeal membrane oxygenation (ECMO) correlate with mortality and abnormal neuroimaging. These findings highlight potential biomarkers for risk stratification in pediatric ECMO patients.
Area of Science:
- Pediatric Critical Care Medicine
- Cardiovascular Research
- Biomarker Discovery
Background:
- Extracorporeal membrane oxygenation (ECMO) support in children can trigger inflammatory and endothelial activation responses.
- Understanding these responses is crucial for improving patient outcomes.
Purpose of the Study:
- To investigate the association between circulating inflammatory, endothelial activation, and fibrinolytic markers and mortality in pediatric ECMO patients.
- To determine if these markers correlate with neurologic outcomes in children undergoing ECMO.
Main Methods:
- Secondary analysis of a prospective observational study involving 99 pediatric ECMO patients.
- Measurement of inflammatory (IFNγ, IL-6, IL-1β, TNFα), endothelial activation (E-selectin, P-selectin, ICAM-3, TM), and fibrinolytic (tPA, PAI-1) markers in plasma during ECMO support.
Main Results:
- Elevated inflammatory biomarkers on ECMO day 1 were associated with abnormal neuroimaging.
- Higher ECMO day 1 and peak levels of IL-6 and PAI-1 were observed in non-survivors.
- No significant association was found between tested biomarkers and long-term neurobehavioral outcomes.
Conclusions:
- Circulating inflammatory, endothelial activation, and fibrinolytic markers are linked to mortality and abnormal neuroimaging in pediatric ECMO patients.
- A proinflammatory and prothrombotic profile is significantly associated with mortality in multivariable models.
- Further research is needed to identify specific profiles associated with neurologic injury and mortality risk.
Background:
Inflammatory and endothelial activation responses during extracorporeal membrane oxygenation (ECMO) support in children are poorly understood. In this study, we aimed to determine if circulating inflammatory, endothelial activation, and fibrinolytic markers are associated with mortality and with neurologic outcomes in children on ECMO.
Methods:
We conducted a secondary analysis of a two-center prospective observational study of 99 neonatal and pediatric ECMO patients. Inflammatory (interferon gamma [IFNγ], interleukin-6 [IL-6], IL-1β, tumor necrosis factor alpha [TNFα]), endothelial activation (E-selectin, P-selectin, intercellular adhesion molecule-3 [ICAM-3], thrombomodulin [TM]), and fibrinolytic markers (tissue plasminogen activator [tPA], plasminogen activator inhibitor-1 [PAI-1]) were measured in plasma on days 1, 2, 3, 5, 7, and every third day thereafter during the ECMO course.
Results:
All ECMO day 1 inflammatory biomarkers were significantly elevated in children with abnormal vs. normal neuroimaging. ECMO day 1 and peak levels of IL-6 and PAI-1 were significantly elevated in children who died compared to those who survived to hospital discharge. Tested biomarkers showed no significant association with long-term neurobehavioral outcomes measured using the Vineland Adaptive Behavioral Scales, Second Edition.
Conclusions:
High levels of circulating inflammatory, endothelial activation, and fibrinolytic markers are associated with mortality and abnormal neuroimaging in children on ECMO.
Impact:
The inflammatory, endothelial activation, and fibrinolytic profile of children on ECMO differs by primary indication for extracorporeal support. Proinflammatory biomarkers on ECMO day 1 are associated with abnormal neurologic imaging in children on ECMO in univariable but not multivariable models. In multivariable models, a pronounced proinflammatory and prothrombotic biomarker profile on ECMO day 1 and longitudinally was significantly associated with mortality. Further studies are needed to identify inflammatory, endothelial, and fibrinolytic profiles associated with increased risk for neurologic injury and mortality through potential mediation of bleeding and thrombosis.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Myocarditis I: Introduction
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:

